C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2001
11/08/2001	WO2001083781A2 14094, a novel human trypsin family member and uses thereof
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083771A2 Human phospholipase c delta 5
11/08/2001	WO2001083770A2 Lipolytic enzyme variant
11/08/2001	WO2001083768A2 Serine-threonine kinase
11/08/2001	WO2001083761A1 Laccase mutants
11/08/2001	WO2001083755A2 Human anti-cd40 antibodies and methods of making and using same
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083745A1 New gtpase-activating protein 1
11/08/2001	WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001	WO2001083739A2 Human pellino polypeptides
11/08/2001	WO2001083738A1 Sex determinative differentiation regulatory factor
11/08/2001	WO2001083705A1 Myocardial cell proliferation-associated genes
11/08/2001	WO2001083561A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083559A2 Production and use of protein variants having modified immunogenecity
11/08/2001	WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083550A2 Gpr22 modulators as appetite-control agents
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083519A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF
11/08/2001	WO2001083515A2 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001082968A1 Cell proliferation inhibitors
11/08/2001	WO2001082966A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	WO2001082965A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	WO2001082963A2 Method of identifying and producing antigen peptides and use thereof as vaccines
11/08/2001	WO2001082960A1 Inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactions
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082901A1 New antibodies to biological membranes
11/08/2001	WO2001082788A2 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001	WO2001038872A3 Assay of isomerised and/or optically inverted proteins
11/08/2001	WO2001038348A3 G-protein coupled receptor htogh35
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors
11/08/2001	WO2001034780A3 Cytochrome p450 oxygenases and their uses
11/08/2001	WO2001034183A3 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001029068A3 A eag gene encoding for a potassium channel
11/08/2001	WO2001021136A9 Compositions and methods for improved detection and classification of neoplasms
11/08/2001	WO2000026256A3 Modified antibodies and antibody fragments with increased duration of activity
11/08/2001	US20010039669 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039332 Monoclonal antibodies to 4,4'-dinitrocarbanilide and a method for analyzing for the drug nicarbazin
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010039027 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
11/08/2001	US20010039008 Immunofluorescence
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	US20010038842 Treating a disease characterized by expression of vascular endothelial growth factor-D (VEGF-D) by a tumor by screening for a VEGF-D expressing tumor, administering a VEGF-D antagonist to prevent binding of VEGF-D to its receptor
11/08/2001	US20010038840 Method for the treatment of fibrosis
11/08/2001	US20010038839 A polypeptide which is capable of binding to one of low affinity immunoglobulin-E receptor (FCEL) or high affinity receptor (FCEH) but which is substantially incapable of binding to other of FCEL OR FCEH
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2420287A1 Anthrax specific antibodies
11/08/2001	CA2409689A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	CA2409686A1 Serine-threonine kinase
11/08/2001	CA2408105A1 Novel proteases
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407893A1 New gtpase-activating protein 1
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407656A1 Myocardial cell proliferation-associated genes
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407601A1 Novel human phospholipase c delta 5
11/08/2001	CA2407443A1 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407292A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	CA2407276A1 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2407068A1 Antigenic peptide fragments of vapa protein, and uses thereof
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2406621A1 Protein variants having modified immunogenicity
11/08/2001	CA2405363A1 Epitope synchronization in antigen presenting cells
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2377877A1 Immunoglobulin bonding protein arrays in plant cells
11/07/2001	EP1152057A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof
11/07/2001	EP1151307A1 Methods for differentiating and monitoring parathyroid and bone status related diseases
11/07/2001	EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
11/07/2001	EP1151114A2 Metalloproteases of the neprilysin family
11/07/2001	EP1151113A2 Human peptidases
11/07/2001	EP1151108A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151092A1 Inhibiting formation of atherosclerotic lesions
11/07/2001	EP1151013A1 Monoclonal antibody
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151011A1 Anti-ccr1 antibodies and methods of use therefor

1 ... 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 ... 1494